Voloridge Investment Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $465,107 - $529,020	600 Added 1.84%	33,209 $29.2 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $9.9 Million - $12.1 Million	14,301 Added 78.11%	32,609 $26.8 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $3.82 Million - $4.54 Million	5,464 Added 42.54%	18,308 $13.2 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $4.65 Million - $5.65 Million	6,830 Added 113.57%	12,844 $10.6 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $4.25 Million - $4.61 Million	6,014 New	6,014 $4.34 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $1.54 Million - $1.81 Million	-2,588 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $11.8 Million - $14.6 Million	-21,705 Reduced 89.35%	2,588 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $12.8 Million - $15.2 Million	22,346 Added 1147.71%	24,293 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $920,541 - $1.09 Million	1,947 New	1,947 $1.09 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $19.3 Million - $23.7 Million	-43,195 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $49.5 Million - $62.9 Million	-103,466 Reduced 70.55%	43,195 $20.9 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $35.6 Million - $43 Million	65,295 Added 80.25%	146,661 $82.1 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $35.6 Million - $46.4 Million	72,124 Added 780.39%	81,366 $50.7 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $3.11 Million - $4.57 Million	9,242 New	9,242 $4.51 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $2.69 Million - $3.73 Million	-8,988 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $3.34 Million - $3.95 Million	8,988 New	8,988 $3.69 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $20.3 Million - $23.6 Million	-57,880 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $16.5 Million - $20 Million	57,880 New	57,880 $20 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $53.5 Million - $66.7 Million	-169,460 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $60.8 Million - $79.6 Million	169,460	169,460 $63.7 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account